House Bill No. 606, introduced by Representative Turner, aims to exempt prescription drugs and insulin from local sales and use taxes in Louisiana. The bill enacts new provisions in R.S. 47:305.2, specifically adding exemptions for drugs prescribed by licensed medical professionals and for both prescription and nonprescription insulin. Additionally, it repeals certain existing provisions in R.S. 47:305.2 that previously governed sales and use tax exemptions, specifically sections (A)(1) and (5).

The proposed law will ensure that purchases of prescription drugs and insulin are exempt from both state and local sales and use taxes, thereby providing financial relief to consumers. This exemption will take effect for taxable periods beginning on or after August 1, 2025. The bill reflects a commitment to making essential medications more affordable for residents of Louisiana.

Statutes affected:
HB606 Original: 47:2(A)(1)
HB606 Engrossed: 47:2(A)(1)